Please select the option that best describes you:

How do you treat metastatic breast cancer which is HR positive, Her2 negative with PIK3CA+ and high tumor mutational burden (>10) who progressed after prior ET+CDK 4/6 and PIK3CA inhibitor therapy?   



Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at Moffitt Cancer Center
Thoughts on Truqap after progression on Alpelisib?...
Medical Oncologist at St Louis Cancer Care LLP
When you run out of targeted options, there is alw...
Medical Oncologist at Avita Health System
It's definitely a possibility. Mechanisms of resis...
Sign in or Register to read more